They sold a million shares/No small peanuts/We know who bought them/see Fridays short data.My guess is INSM falls into the 8's if there is no news.
did viropharma have buyer interest ? or is that now dead.Sorry its summer and I have been fishing in the No Carolina mountains.
this is a stupid thread/You can not value Insmed/only someone who pays can.30 dollars is 1.3 B/see how stupid you sound?
No surprise.This is what Insmed is valued at 380M\\\This was the avg price the weekend before the results and the company made more shares available at a lower price for institutions
LISTEN TO THE CALL!!!
There's your answer to why the company did not do a trial in the United States.
The FDA wanted one much longer and now with weak results I say the company declines one because the longer trial would show even more inferiority.SO MAYBE THEY DONT HAVE TO A DILUTION OR A TRIAL.
Also the side effects many questioned with equally vague answers.
anyone who listened to the call and who own shares and didn't sell will learn soon enough.
Point was the FDA will require a trial now., ,I suspected this since the placement was announced. Terry is a great trader, Vedanta's are for losers on a blog.
If you enjoy that the primary endpoint of non-inferiority,then yes it did/the secondary data was oddly missing from the company/unless it has been disseminated since.biowatchers wanted superiority/they didn't get it. The drug has been delayed another 2years in the US.
The data released by the company shows this fact.